UNVERIFIEDSingle Source
STAT+: Proposed ‘preclinical obesity’ diagnosis ignites global debate among experts
Stat News|4/2/2026
WL
weight loss
38 stories tracked
Executive summary being generated...
Lindy
0
Breaking
0
Unverified
19
Activity (Last 30 Days)
1
1
1
1
1
1
2
1
1
1
2026-03-042026-04-02
Top Publishers
Stat News18 stories
Ars Technica1 stories
Stories (Latest First)
UNVERIFIEDSingle Source
Eli Lilly’s obesity pill approved by FDA, setting up fierce competition with Novo Nordisk
Stat News|4/1/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk’s high-dose Wegovy approved in the U.S.
Stat News|3/19/2026
UNVERIFIEDSingle Source
STAT+: Eli Lilly’s ‘triple-G’ drug leads to significant blood sugar, weight reductions in diabetes trial
Stat News|3/19/2026
UNVERIFIEDSingle Source
Opinion: Semaglutide is going off-patent in India. But will people who need it be able to get it?
Stat News|3/17/2026
UNVERIFIEDSingle Source
STAT+: The FDA is targeting telehealth marketing of GLP-1 drugs. Who’s prescribing them?
Stat News|3/12/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk, Hims reach deal to end bitter dispute over Wegovy sales
Stat News|3/9/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk’s Wegovy and Ozempic shots could be made for as little as $3 a month, analysis finds
Stat News|3/6/2026
UNVERIFIEDSingle Source
STAT+: Eli Lilly launches program for employers to subsidize cost of obesity drug outside insurance
Stat News|3/5/2026
UNVERIFIEDSingle Source
Opinion: Obesity drugs may silence the ‘drug noise’ behind all addiction
Stat News|3/4/2026
UNVERIFIEDSingle Source
6 in 10 women will develop heart disease or stroke by 2050, heart association projects
Stat News|2/25/2026
UNVERIFIEDSingle Source
STAT+: Will Novo Nordisk’s slashing of obesity drug prices save patients’ money? It depends
Stat News|2/24/2026
UNVERIFIEDSingle Source
Opinion: My biggest GLP-1 ethical problem: patients who don’t want to stop
Stat News|2/19/2026
UNVERIFIEDSingle Source
STAT+: Lawsuit against Hims & Hers should be ‘wake-up call’ for compounders, Novo chief counsel says
Stat News|2/9/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk accuses Hims & Hers of ‘illegal mass compounding’ over a cheaper version of Wegovy pill
Stat News|2/5/2026
UNVERIFIEDSingle Source
A sneak peek of pharma’s Super Bowl ads: GLP-1s, tight ends, and more
Stat News|2/5/2026
UNVERIFIEDSingle Source
STAT+: Novo Nordisk sees lower sales, profits as Wegovy faces growing competition
Stat News|2/3/2026
UNVERIFIEDSingle Source
A weird, itchy rash is linked to the keto diet—but no one knows why
Ars Technica|1/24/2026